Remarkably, heterozygous rnpc3 reduced liver overgrowth in a zebrafish model of hepatocellular carcinoma (HCC), underscoring the potential of zebrafish genetic screens in identifying new cancer therapy targets. This evidence concerns the gene RNPC3 and cancer.